Artivion, Inc.
Artivion, Inc. (AORT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AORT · as of Jun 8, 2026
Key Statistics
Explore Artivion, Inc. Data
aort stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The AORT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $48.00, representing +138.57% upside from the current price of $20.12.
Competitors & Peers
aort competitorsAORT
ADUS
ARDT
BKD
COGT
INSPStock Performance
Full HistoryAbout Artivion, Inc.
Artivion, Inc. Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent fo…
what is artivion, inc. · aort stock overview · artivion, inc. company profile · who is artivion, inc. ceo · aort NYSE · artivion, inc. headquarters · artivion, inc. business segments
About Stock Overview & Key Data
Artivion, Inc. (AORT) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Feb 12, 1993. As of the latest trading session, AORT stock price is $20.12, with a market capitalization of $976.7M. The stock has returned -31.07% over the past 12 months and -55.89% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Artivion, Inc. stock is Buy, with an average 12-month price target of $48.00. In fiscal year 2025, Artivion, Inc. reported revenue of $441.3M and net income of $9.8M. For detailed data — including Artivion, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Artivion, Inc. (AORT) stock price is $20.12. The stock is traded on NYSE under the ticker symbol AORT. The 52-week range is $19.16 – $48.25.